Estée Lauder stock: recovery is real, but the valuation leaves little room
EL stock analysis and fair value · bull and bear case
The call: SageNoodle rates Estee Lauder Companies Overvalued: base-case fair value USD 77 against a price of USD 98, 21% below the quote on a 3–5 years horizon. There is no verified new event that explains the share’s move today; the latest company results were released August 19, 2026.
Estée Lauder stock is rising today, but the cause is not established by the available reporting. Fiscal 2026 recovery supports the business; the price already asks for further improvement.
Valuation as of 4 Oct 2026 · Quote currency: USD. Latest quote: Fri, 09 Oct 2026 19:16:08 GMT.
Written with AI from the linked sources and reviewed by a SageNoodle editor. How we work.
Latest quote
USD 98.15
At publication
USD 91.97
Fair value
USD 77.40
Upside
-21.1%
P/E at publication
187.7x
EV/EBITDA
Not available
FCF yield
3.9%
ROIC Not available · Horizon 3–5 years
Why Estee Lauder Companies (EL) stock is mispriced
- 01
There is no verified new event that explains the share’s move today; the latest company results were released August 19, 2026.
- 02
Fiscal 2026 showed a genuine operating recovery, with organic sales growth and higher adjusted margins, but the company still has to convert that progress into sustained growth and cash.
- 03
At $91.97, the shares trade above a preliminary $77.40 base-case value using fiscal 2027 adjusted EPS guidance and an assumed 24x earnings multiple.
What Estee Lauder Companies does and how it makes money
The Estée Lauder Companies (NYSE: EL) sells prestige skin care, makeup, fragrance and hair-care products under brands including Estée Lauder, La Mer, M·A·C, Jo Malone London, TOM FORD and The Ordinary. The company says its products are sold in approximately 150 countries and territories. It earns revenue from product sales through retail partners and its own channels; its fiscal 2026 release describes expansion on Amazon and TikTok Shop, Sephora distribution, and new fragrance stores. Skin care and makeup are its largest reported product categories, while fragrance is growing fastest in the latest annual results. Geographic performance spans the Americas, EUKEM and Asia/Pacific, with mainland China separately highlighted. The business depends on brand appeal, product launches, retailer relationships and consumer demand, while carrying exposure to travel retail, foreign exchange, tariffs and changing shopping preferences. Fiscal 2026 results
For the financial history and all coverage, see ESTEE LAUDER COMPANIES INC (EL) company research.
The daily move has no verified company-specific trigger
Estée Lauder is up 2.0% today at $91.97. There was one Reddit mention and no fresh headlines in the prior day. Those are descriptions of attention and price action, not evidence of what caused either. The latest company development is its fiscal 2026 results, released August 19, 2026. No new announcement today has been established.
The August release reported a better year: net sales grew 5% to $15.049 billion, while organic sales, which exclude foreign-exchange effects and certain restructuring-related returns, rose 3%. The company affirmed fiscal 2027 organic sales growth guidance of 3% to 5%. This recovery may help explain why investors care about the shares, but it cannot be presented as the cause of today’s move. Fiscal 2026 results
The recovery is visible in margins, but the mix matters
The stronger evidence is profitability. Fiscal 2026 gross margin increased to 75.5% from 74.0%; adjusted operating margin rose to 11.2% from 8.0%. Management attributes the improvement in part to its Profit Recovery and Growth Plan, including procurement and expense efficiencies. The company also says it increased consumer-facing investment 4% for the full year excluding foreign-currency effects. Cost savings are doing useful work when they both restore margins and help fund brand support.
There is still a gap between the adjusted picture and reported earnings. Reported operating margin was 5.2%, and reported diluted EPS was $0.50, against adjusted EPS of $2.51. Fiscal 2026 included $823 million of restructuring and other charges and an $84 million securities-litigation loss contingency. These items do not make the underlying improvement imaginary, but adjusted earnings should not be mistaken for the cash or profit currently reaching shareholders without recurring costs. The company says further PRGP benefits are expected in fiscal 2027, while restructuring charges are also expected to continue. Fiscal 2026 results
What does $91.97 assume about the next year?
For a preliminary valuation, use management’s fiscal 2027 adjusted diluted EPS guidance of $3.10 to $3.35, with the midpoint of $3.225. Applying an analyst-assumed 24x price-to-earnings multiple gives $77.40 per share: $3.225 multiplied by 24. This is an illustrative earnings-based estimate, not company guidance. It excludes neither future restructuring costs nor the risk that adjusted earnings prove a poor guide to durable cash generation.
The $91.97 share price is about 28.5x that guidance midpoint. That premium can be justified if sales growth broadens and the planned margin recovery sticks, but it leaves less cushion if the business stalls. The trailing P/E of 187.7x is distorted by reported trailing EPS of $0.49, so it is a poor standalone measure of normalized earnings. Free cash flow improved to $1.32 billion in fiscal 2026 from $0.67 billion, but management forecasts fiscal 2027 operating cash flow of $1.3 billion to $1.4 billion, down from $1.77 billion, citing restructuring payments and working-capital needs. Cash generation, then, may not follow adjusted EPS upward in a straight line. Fiscal 2026 results
What would change the long-term case?
The operating thesis has improved, not been settled. Fragrance delivered 10% organic growth in fiscal 2026, and skin care grew 4%; makeup was virtually flat and hair care declined 1%. For fiscal 2027, management expects makeup to return to growth, but that is a forecast, not a result. The contrast matters: growth is broadening across regions, yet the categories and brands are not all moving together.
The next useful evidence is whether quarterly sales growth holds after the first-half timing benefits management expects from product launches and travel-retail shipments, whether makeup turns positive, and whether margins improve while consumer-facing spending continues. Also watch cash flow against the company’s lower fiscal 2027 outlook. If reported results fall short of the operating recovery embedded in adjusted EPS guidance, the valuation has little room to shrug. Today’s attention does not settle any of those questions.
Follow SageNoodle on Google
Estee Lauder Companies revenue, margins and cash flow
Revenue (USD, billions)
Margins (%)
Free cash flow (USD, billions)
Estimated ROIC (%)
Net debt (USD, billions)
Monetary values are in USD; revenue, FCF and net debt are in billions; EPS is per share. Missing values appear as gaps and “Not available.” Source: SEC EDGAR XBRL filings, latest restated values; quarterly cash flow derived from year-to-date figures; Q4 = fiscal year minus nine months. ROIC is NOPAT (21% tax) over debt plus equity.
| Period | Revenue | Gross % | Op % | FCF | EPS | ROIC % | Net debt |
|---|---|---|---|---|---|---|---|
| FY2017 | 11.8 | 79.4 | 14.4 | 1.29 | 3.35 | Not available | Not available |
| FY2018 | 13.7 | 79.2 | 15.0 | 1.93 | 2.95 | Not available | Not available |
| FY2019 | 14.9 | 77.2 | 15.6 | 1.77 | 4.82 | Not available | Not available |
| FY2020 | 14.3 | 75.2 | 4.24 | 1.66 | 1.86 | Not available | Not available |
| FY2021 | 16.2 | 76.4 | 16.1 | 2.99 | 7.79 | Not available | Not available |
| FY2022 | 17.7 | 75.7 | 17.9 | 2.00 | 6.55 | Not available | Not available |
| FY2023 | 15.9 | 71.3 | 9.48 | 0.73 | 2.79 | Not available | Not available |
| FY2024 | 15.6 | 71.7 | 6.21 | 1.44 | 1.08 | Not available | Not available |
| FY2025 | 14.3 | 74.0 | -5.48 | 0.67 | -3.15 | Not available | Not available |
| FY2026 | 15.1 | 75.5 | 5.18 | 1.32 | 0.50 | Not available | Not available |
What Estee Lauder Companies management has said
Guidance
Direct quote
“Organic net sales growth of 3% to 5%”
Margins
Paraphrased commentary
Management forecasts fiscal 2027 adjusted operating margin of 12.7% to 13.5%, attributing the outlook in part to continued operating leverage in non-consumer-facing expenses and modest gross-margin expansion.
Capex
Paraphrased commentary
The company expects fiscal 2027 operating cash flow of $1.3 billion to $1.4 billion, down from fiscal 2026, citing higher restructuring payments and working-capital needs.
Estee Lauder Companies fair value: bear, base and bull scenarios
Dot marks the latest quote of USD 98.15.
Bear
25%USD 48
Direct equity valuation using fiscal 2027 adjusted EPS guidance midpoint and an assumed 15x P/E.
Equity value USD 17.65B ÷ 0.365B diluted shares
- Fiscal 2027 adjusted EPS
- $3.225, midpoint of company guidance
- P/E multiple
- 15x analyst assumption
- Calculation
- $3.225 × 15 = $48.375 per share
Growth and margin delivery disappoint; a lower multiple reflects weaker confidence in normalized earnings.
Base
50%USD 77
Direct equity valuation using fiscal 2027 adjusted EPS guidance midpoint and an assumed 24x P/E.
Equity value USD 28.24B ÷ 0.365B diluted shares
- Fiscal 2027 adjusted EPS
- $3.225, midpoint of company guidance
- P/E multiple
- 24x analyst assumption
- Calculation
- $3.225 × 24 = $77.40 per share
Fiscal 2027 growth and margin recovery broadly track management’s outlook, while the current price remains ahead of this earnings-based estimate.
Bull
25%USD 100
Direct equity valuation using fiscal 2027 adjusted EPS guidance midpoint and an assumed 31x P/E.
Equity value USD 36.47B ÷ 0.365B diluted shares
- Fiscal 2027 adjusted EPS
- $3.225, midpoint of company guidance
- P/E multiple
- 31x analyst assumption
- Calculation
- $3.225 × 31 = $99.975 per share
Sales recovery broadens and margin expansion convinces investors that improved adjusted earnings are durable, supporting a higher multiple.
Estee Lauder Companies (EL) stock: bullish vs bearish case
Bull case
- Fiscal 2026 organic sales grew 3%, with growth in each geographic region, and fiscal 2027 guidance calls for 3% to 5% organic growth.
- Adjusted operating margin expanded to 11.2% in fiscal 2026, with management forecasting 12.7% to 13.5% in fiscal 2027.
- Fragrance and skin care growth, alongside a stronger free-cash-flow year, provides evidence that the recovery is not confined to cost reductions.
Bear case
- Reported fiscal 2026 diluted EPS was only $0.50 versus adjusted EPS of $2.51; charges and adjustments remain substantial.
- Management expects fiscal 2027 operating cash flow to fall to $1.3 billion to $1.4 billion from $1.77 billion in fiscal 2026.
- Makeup was virtually flat and hair care declined in fiscal 2026; management’s anticipated makeup recovery is not yet demonstrated.
- The share price implies about 28.5x the midpoint of fiscal 2027 adjusted EPS guidance, leaving limited valuation protection if execution falters.
Estee Lauder Companies stock risks
| Risk | Severity | Probability | Rationale |
|---|---|---|---|
| Execution of restructuring and margin recovery | High | Medium | The fiscal 2027 margin outlook depends on operating leverage and continued benefits from the Profit Recovery and Growth Plan; the company also expects further restructuring charges. |
| Consumer demand and brand performance | High | Medium | Fiscal 2026 makeup was virtually flat and hair care declined, while the fiscal 2027 outlook assumes a makeup return to growth. Consumer preferences and product launches can disrupt that plan. |
| Travel retail, geopolitical and tariff exposure | High | Medium | The company identifies travel retail and geopolitical conditions as relevant to sales, and its outlook assumes no deterioration in geopolitical conditions or related impacts, including tariffs and consumer sentiment. |
| Valuation risk | High | High | At $91.97, the share price is above the preliminary base-case valuation of $77.40 based on fiscal 2027 adjusted EPS guidance and an assumed 24x multiple. |
Estee Lauder Companies catalysts: what could move EL stock
- Next quarterly results; date not specified in supplied documentsNeutral
First fiscal 2027 results
The results will show whether sales and margins follow management’s outlook and how cash flow absorbs restructuring payments and working-capital needs.
- Fiscal 2027; timing not specifiedNeutral
Profit Recovery and Growth Plan benefits
The company expects the vast majority of full run-rate benefits during fiscal 2027; delivery would test the margin-recovery thesis.
Estee Lauder Companies fair value history
| Period | Fair value | Verdict | Note |
|---|
Estee Lauder Companies news
Estee Lauder Companies stock: common questions
- Is Estee Lauder Companies (EL) stock undervalued or overvalued?
- SageNoodle rates Estee Lauder Companies Overvalued: base-case fair value USD 77 against a price of USD 98, 21% below the quote on a 3–5 years horizon. There is no verified new event that explains the share’s move today; the latest company results were released August 19, 2026.
- What is Estee Lauder Companies's fair value?
- Bear USD 48 (25% probability, Direct equity valuation using fiscal 2027 adjusted EPS guidance midpoint and an assumed 15x P/E.); Base USD 77 (50% probability, Direct equity valuation using fiscal 2027 adjusted EPS guidance midpoint and an assumed 24x P/E.); Bull USD 100 (25% probability, Direct equity valuation using fiscal 2027 adjusted EPS guidance midpoint and an assumed 31x P/E.). Fiscal 2027 growth and margin recovery broadly track management’s outlook, while the current price remains ahead of this earnings-based estimate.
- What is the bull case for EL stock?
- Fiscal 2026 organic sales grew 3%, with growth in each geographic region, and fiscal 2027 guidance calls for 3% to 5% organic growth. Adjusted operating margin expanded to 11.2% in fiscal 2026, with management forecasting 12.7% to 13.5% in fiscal 2027. Fragrance and skin care growth, alongside a stronger free-cash-flow year, provides evidence that the recovery is not confined to cost reductions.
- What is the bear case for EL stock?
- Reported fiscal 2026 diluted EPS was only $0.50 versus adjusted EPS of $2.51; charges and adjustments remain substantial. Management expects fiscal 2027 operating cash flow to fall to $1.3 billion to $1.4 billion from $1.77 billion in fiscal 2026. Makeup was virtually flat and hair care declined in fiscal 2026; management’s anticipated makeup recovery is not yet demonstrated.
- What are the biggest risks to Estee Lauder Companies stock?
- Execution of restructuring and margin recovery (High severity): The fiscal 2027 margin outlook depends on operating leverage and continued benefits from the Profit Recovery and Growth Plan; the company also expects further restructuring charges. Consumer demand and brand performance (High severity): Fiscal 2026 makeup was virtually flat and hair care declined, while the fiscal 2027 outlook assumes a makeup return to growth. Consumer preferences and product launches can disrupt that plan. Travel retail, geopolitical and tariff exposure (High severity): The company identifies travel retail and geopolitical conditions as relevant to sales, and its outlook assumes no deterioration in geopolitical conditions or related impacts, including tariffs and consumer sentiment.
- What could move EL stock next?
- Next quarterly results; date not specified in supplied documents: First fiscal 2027 results. The results will show whether sales and margins follow management’s outlook and how cash flow absorbs restructuring payments and working-capital needs. Fiscal 2027; timing not specified: Profit Recovery and Growth Plan benefits. The company expects the vast majority of full run-rate benefits during fiscal 2027; delivery would test the margin-recovery thesis.
Company reference pages
Browse company filings and market quotes to check the latest information. These pages update over time and are separate from the documents cited in this report.